What does carcinoembryonic antigen (CEA) mean?
Dec 21, 2021
Source: Cainiu Health
Dr. Liu Dahai
Introduction
Carcinoembryonic antigen (CEA) is an auxiliary diagnostic marker for gastrointestinal tumors. Elevated CEA levels in a patient typically suggest the presence of a gastrointestinal tumor. However, elevated CEA levels may also occur in individuals who smoke or have cardiovascular disease, diabetes, pregnancy, or disorders affecting the gastrointestinal tract, lungs, or liver.
Diagnosing cancer requires a variety of methods, one of the most important being tumor-specific biomarkers. Carcinoembryonic antigen (CEA) is one such specific biomarker. However, an elevated CEA level detected during testing does not necessarily confirm a cancer diagnosis. Although CEA is associated with cancer, many patients become highly anxious upon hearing this term. So, what exactly is carcinoembryonic antigen? Let’s explore this further.
What Is Carcinoembryonic Antigen?
Carcinoembryonic antigen (CEA) is an auxiliary diagnostic marker for gastrointestinal tumors. Elevated CEA levels often suggest the presence of gastrointestinal malignancies. However, elevated CEA may also occur in non-malignant conditions—including smoking, cardiovascular disease, diabetes, pregnancy, and benign disorders affecting the gastrointestinal tract, lungs, or liver. Therefore, an elevated CEA level alone cannot definitively indicate cancer or tumor presence; currently, CEA serves only as an adjunctive diagnostic tool.
Knowledge Extension: What Are the Functions of Carcinoembryonic Antigen?
1. Effectively eliminates residual cancer cells and microscopic disease foci remaining after surgery, radiotherapy, or chemotherapy—thereby helping prevent tumor recurrence and metastasis.
2. Enhances tumor sensitivity to radiotherapy, reduces radiotherapy-related toxicities, counteracts the immunosuppressive effects of chemotherapeutic agents, increases tumor sensitivity to chemotherapy, and thereby improves overall chemotherapy efficacy.
3. As biological immunotherapy exerts both immunomodulatory and somatic cell repair effects, many patients—especially those undergoing or recovering from radiotherapy or chemotherapy—experience significant improvements including alleviation or resolution of gastrointestinal symptoms, improved skin luster, lightening of age spots, disappearance of varicose veins, cessation of hair loss with regrowth, and reversal of gray hair to black hair (“rejuvenating” manifestations). Additionally, patients commonly report marked improvements in mental alertness and physical stamina—substantially enhancing quality of life for cancer patients.
4. For advanced-stage cancer patients who are ineligible for surgery or whose cancers have recurred or metastasized, biological immunotherapy can rapidly alleviate clinical symptoms. Many patients experience tumor shrinkage—or even complete regression—and some achieve long-term survival with stable disease. Moreover, for patients unresponsive to conventional radiotherapy or chemotherapy—or those who have developed resistance to chemotherapeutic agents—biological immunotherapy remains a viable option to extend survival.
The above provides an overview of what carcinoembryonic antigen (CEA) means. We hope this information has been helpful to you.
